QNRX Buy Disclosure
Carter Denise P. · SEC Form 4 · Filed Sep 1, 2026
Buy
Reported value range
Not reported
Carter Denise P. Chief Operating Officer
QNRX
Transaction date
Aug 31, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed 2 days later
QNRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Ordinary Warrants (Right to Buy) on ADS
- Quantity / price
- 10,245 shares
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001104659-26-104405
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$99.99K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. QNRX | Buy | Aug 31, 2026 | $99.99K |
| Quoin Pharmaceuticals, Ltd. QNRX Current | Buy | Aug 31, 2026 | Not reported |